lobbying_activities: 2814119

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2814119	7f528e02-ffc9-4fe8-8210-da5ae1dca9dd	Q2	RED+BLUE STRATEGIES	400693064	GE HEALTHCARE	2022	second_quarter	HCR	H.R. 7667 - The Food and Drug Amendments of 2022 Act - Issues related to FDA and Medical Devices. S 4348 - The FDA Safety and Landmark Advancements Act - Issues related to FDA and Medical Devices. H.R.4479/S.2609 - The FIND Act - Legislation focused on ensuring equitable access to radio pharmaceuticals. PL 117- 2- The American Rescue Plan Act - Implementation issues related to ensuring access to technologies for the fight against COVID-19. Issues related to ensuring that vital information regarding hospital bed availability and other key issues are made available in all states to ensure patient access and safety during disasters and emergencies.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2022-07-02T15:26:23-04:00